These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7490443)

  • 21. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and forthcoming therapies for viral hepatitis.
    Carreño V; Quiroga JA
    J Hepatol; 1996; 24(2 Suppl):74-6. PubMed ID: 8836893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of biotherapy in multiple myeloma].
    Petrucci MT; Tafuri A; Mandelli F
    Recenti Prog Med; 2000 Oct; 91(10):488-93. PubMed ID: 11072735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hematopoietic growth factors and anaphylaxis].
    Balaguer AA; Berrocal Jaime A; Noguerón Martínez E; Camps Herrero C
    Med Clin (Barc); 1999 May; 112(15):598. PubMed ID: 10365392
    [No Abstract]   [Full Text] [Related]  

  • 26. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel approaches to the prevention and therapy of neonatal bacterial sepsis.
    Perez EM; Weisman LE
    Clin Perinatol; 1997 Mar; 24(1):213-29. PubMed ID: 9099511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis in cancer patients treated with hematopoietic growth factors--a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH.
    Barbui T; Finazzi G; Grassi A; Marchioli R
    Thromb Haemost; 1996 Feb; 75(2):368-71. PubMed ID: 8815592
    [No Abstract]   [Full Text] [Related]  

  • 29. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human erythropoietin in combination with other hematopoietic cytokines in attenuating chemotherapy-induced multilineage myelosuppression: brief communication.
    Vadhan-Raj S
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):16-8. PubMed ID: 8714611
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on therapeutic activity of benzoxazinorifamycin KRM-1648 in combination with other antimicrobial agents and biological response modifiers interferon-gamma and granulocyte-macrophage colony-stimulating factor against M. leprae infection in athymic nude mice.
    Maw WW; Tomioka H; Sato K; Saito H
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):345-51. PubMed ID: 9401487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-evaluating the use of growth factors as adjuvant treatment of chronic hepatitis C.
    Worman HJ
    Hepatology; 2007 Oct; 46(4):1307-8; author reply 1307-8. PubMed ID: 17894319
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis].
    Hospers GA; de Wolf JT; Hazenberg BP; Vellenga E
    Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2152-4. PubMed ID: 7694163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines.
    Arellano M; K Waller E
    Curr Hematol Rep; 2004 Nov; 3(6):424-31. PubMed ID: 15496276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Foote M; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
    [No Abstract]   [Full Text] [Related]  

  • 39. Concurrent use of corticosteroids and antimicrobial drugs in the treatment of infectious diseases in large animals.
    Jenkins WL
    J Am Vet Med Assoc; 1984 Nov; 185(10):1145-9. PubMed ID: 6392244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet's syndrome treated with high-dose intravenous immunoglobulin.
    Calixto R; Menezes Y; Ostronoff M; Sucupira A; Botelho LF; Florencio R; Martins M; Souto Maior AP
    J Clin Oncol; 2014 Feb; 32(5):e1-2. PubMed ID: 24395855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.